Archives for April 2010

Engage with independent insights, opinions, and analysis from an array of leaders in cardiology.
Avatar of John Mandrola, MD, FACC

Board Examinations, Again… (16 Apr 2010)

John Mandrola, MD, FACC

CardioExchange welcomes this guest post reprinted with permission from Dr. John M, a blog by private-practice electrophysiologist and CardioExchange member, Dr. John Mandrola. It was a brightly lit wide open room with many cubicles arranged on the periphery.  The test takers were grown-ups, but all carried that worried student look.  The secretary at the desk who checked you in made TSA people seem jovial.  No personal effects were allowed, including a full-fledged divorce of the cell phone. Mysteriously, the test was devoid of ovals or pencils. A former senior partner… Continue Reading

Avatar of Juan J. Rivera, MD, MHS

Are You Really a Cardiovascular Prevention Specialist? (13 Apr 2010)

Juan Rivera, MD, MHS

I call myself a “preventive cardiologist,” but what makes me different from other cardiologists? Many academic centers categorize cardiovascular prevention as a distinct field within cardiology that merits its own label, sub-department, and leadership. Outside the university, however, the distinction may seem, well, academic. But not to me. Although I’ve been in practice for only 1 year, I have on many occasions found myself defending against statements such as “Every cardiologist practices prevention” and “We all do a lipid panel on our patients.” Some even say, “I order a CRP… Continue Reading

Avatar of Mikhail Kosiborod, MD

Elevated Glucose Levels and IV Contrast Deliver a Double Hit to Renal Function (7 Apr 2010)

Mikhail Kosiborod, MD

Hyperglycemia before coronary angiography raises the risk for contrast-induced, acute kidney injury (CI-AKI). My colleagues and I reached this conclusion in an investigation of the relationship between pre-procedural glucose levels and CI-AKI in 6,358 patients who underwent coronary angiography during hospitalization for MI. We found found a high risk for CI-AKI among those patients who had pre-procedural hyperglycemia but no known diabetes, even when the baseline renal function was normal. While diabetes is a known risk factor for CI-AKI, it has not been clear until now that the risk extends to hyperglycemic patients without… Continue Reading